Título: Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch Syndrome
Autores: Pérez-Carbonell, Lucía
Alenda, Cristina
Payá, Artemio
Castillejo, Adela
Barberá, Víctor Manuel
Guillén-Ponce, Carmen
Rojas, Estefanía
Acame, Nuria
Gutiérrez-Aviñó, Francisco J.
Castells, Antoni
Llor, Xavier
Andreu, Montserrat
Soto, José Luis
Jover, Rodrigo
Fecha: 2012-01-10
2012-01-10
2010-07
Publicador: RUA Docencia
Fuente:
Tipo: info:eu-repo/semantics/article
Tema: MLH1 methylation
Genetic testing
Lynch Syndrome
Genética
Descripción: Inactivation of MLH1 due to promoter hypermethylation strongly suggests a sporadic origin, providing exclusion criteria for Lynch syndrome. The aim of this study is to compare the utility of methylation analysis of MLH1 and BRAF V600E mutations for the selection of patients with MLH1 negative colorectal cancer for genetic testing. MLH1 methylation status was evaluated by MethyLight and methylation-specific MLPA (MS-MLPA) in tumor DNA from 73 colorectal cancer patients with loss of MLH1 protein expression. These tumors were analyzed for BRAF V600E mutations, and genetic testing for germline MLH1 mutations was performed in all corresponding patients. Ten patients had germline mutations in MLH1 and none of their tumors showed significant MLH1 methylation or BRAF V600E mutation. MLH1 genetic testing excluded patients by MethyLight in 47 patients (64%), by MS-MLPA in 49 (67%), and BRAF V600E mutation in only 25 patients (34%) (χ2P = 0.00001). Specificity was 75% for MethyLight, 78% for MS-MLPA and 40% for BRAF V600E mutation. The use of MethyLight or MS-MLPA instead of BRAF mutation resulted in a cost reduction of 41% and 45%, respectively, per every MLH1 mutation detected. Taken together, methylation analysis of MLH1 shows better performance characteristics than BRAF V600E mutation in the selection of patients for genetic testing of MLH1, especially when using MS-MLPA.
Supported in part by a grant from the Fundación de la CV para la investigación en el Hospital General Universitario de Alicante (Grupos consolidados 2008). L.P.-C. is the recipient of a grant from the Instituto de Salud Carlos III (FI07/00303). N.A. is supported by Schering-Plough.
Idioma: Inglés

Artículos similares:

Choosing the correct paradigm for unknown words in rule-based machine translation systems por Sánchez Cartagena, Víctor Manuel,Esplà Gomis, Miquel,Sánchez Martínez, Felipe,Pérez Ortiz, Juan Antonio
Using external sources of bilingual information for on-the-fly word alignment por Esplà Gomis, Miquel,Sánchez Martínez, Felipe,Forcada Zubizarreta, Mikel L.
10